Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity

Published:2020-03 Issue:6 Volume:30 Page:126984
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Bazin Hélène G.,Bess Laura S.,Livesay Mark T.,Li Yufeng,Cybulski Van,Miller Shannon M.,Johnson David A.,Evans Jay T.

Funder

NIAID

University of Montana

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. Recent advances of vaccine adjuvants for infectious diseases;Lee;Immune Netw,2015

2. Viral vaccines and CTL response;Woolard;J Biomed Biotechnol,2010

3. Toll-like receptors: the Swiss army knife of immunity and vaccine development;Dowling;Clin Trans Immunol,2016

4. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants;Vasilakos;Expert Rev Vaccines.,2013

5. Toll-like receptors: activation, signaling and transcriptional modulation;De Nardo;Cytokine,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses;Pharmaceutics;2024-01-13

2. Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD;Vaccines;2023-12-23

3. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination;Scientific Reports;2022-10-18

4. Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine;Pharmaceutics;2022-07-12

5. A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates;Chemical Communications;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3